Monthly Aggregated Rapid Detox Treatment Data – February 2016

At Rapid Detox by the Waismann Method®, our primary focus is to provide the safest and most thorough rapid detox from opioids. We treat patients from around the world, spanning various age groups. Below are some of the anonymized monthly statistics of patients we have recently treated in February 2016.

Reported Drugs Detoxed

Opioids come in a variety of formulations and under a plethora of brand names. Here are the opioids we treated in February 2016.

Approximately 32% of the opioids we detoxed were oxycodone-based drugs: Oxycodone, OxyContin, and Percocet. OxyContin is a trade name for Oxycodone. Percocet is a trade name for the Oxycodone and Acetaminophen.

About 24% came from poppy-based opioids, such as Heroin, Morphine, and MS Contin.

The replacement drug buprenorphine (also known by the trade name Suboxone) accounted for about 16% of the drugs detoxed.

Coming in also at 16% were Hydrocodone-based drugs, such as Vicodin and Lortab. Both Vicodin and Lortab are brand names for a combination of Hydrocodone and Acetaminophen.

Nearly 8% of opioids detoxed were hydromorphone-based drug. Hydromorphone goes by the trade name Dilaudid.

Lastly, 4% of opioids detoxed were based on fentanyl.

Aggregated Data | 2016 02 | Drugs Detoxed

Travel

A little over 60% of our patients traveled from out state seeking our exclusive treatment center in California.  About 6% of our patients flew to California, internationally. Suffice it to say, the remaining one-third of our patients were from within California.
Aggregated Data | 2016 02 | Travel

Length of Stay

Approximately 72% of our patients stayed with us for 7-9 days. About 28% stayed with us for 10-14 days. The length of stay is determined by our medical director, based on each patient’s individual circumstances, including but not limited to: age, drugs taken, medical history, and overall health.
Aggregated Data | 2016 02 | Length of Stay

Age

We treat patients from across various age groups. For the month of February, about one-third of our patients were between the ages of 50-64. At about 28% respectively, were patients between the ages of 40-49 and 22-29. Approximately 11% of patients were 30-39 years of age.
Aggregated Data | 2016 02 | Patient Age